According to Cannabics Pharmaceuticals latest financial reports the cash on hand of CNBX is $129.70K, an increase of 10.37% to 2022. At the end of 2022 company had $117.52K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $129.70K | 10.37% |
2022 | $117.52K | -91.52% |
2021 | $1.39M | 78.30% |
2020 | $777.61K | -77.92% |
2019 | $3.52M | 152.76% |
2018 | $1.39M | - |